ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 1073 out of 6782

$479K Total Retail Price of All Prescriptions

Rank: 1463 out of 6782

557 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 498 457 125 1 1
LISINOPRIL 463 427 97 2 4
AMLODIPINE BESYLATE 435 419 95 3 2
METFORMIN HCL 386 354 83 4 8
METOPROLOL TARTRATE 271 271 54 5 13
ALENDRONATE SODIUM 261 261 50 6 14
LOVASTATIN 259 247 52 7 16
HYDROCHLOROTHIAZIDE 244 221 57 8 12
LEVOTHYROXINE SODIUM 220 199 40 9 3
GLIMEPIRIDE 217 212* 47 10 48
HYDROCODONE-ACETAMINOPHEN 206 151 58 S3 11 6
LOSARTAN POTASSIUM 193 173 45 12 10
ATENOLOL 191 186* 38 13 9
ATORVASTATIN CALCIUM 184 179* 48 14 5
FUROSEMIDE 182 177* 37 15 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 175* 46 16 41
WARFARIN SODIUM 170 170 32 17 17
OMEPRAZOLE 164 159* 43 18 7
METOPROLOL SUCCINATE 135 130* 25 19 22
GABAPENTIN 131 110 31 20 15
TAMSULOSIN HCL 129 124* 27 21 21
PRAVASTATIN SODIUM 126 106 27 22 20
VALSARTAN-HYDROCHLOROTHIAZIDE 117 112* 19 23 75
CARVEDILOL 103 98* 25 24 23
DIOVAN 96 84 18 25 26
ALLOPURINOL 89 84* 24 26 33
NIFEDIPINE ER 88 72 22 27 80
PANTOPRAZOLE SODIUM 82 77* 15 28 28
BENAZEPRIL HCL 76 71* 14 29 27
NAMENDA 63 <11 <11 30 36
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 14 30 51
CLONIDINE HCL 60 55* 15 32 60
DONEPEZIL HCL 58 58 11 33 31
ADVAIR DISKUS 57 52* 12 34 49
POTASSIUM CHLORIDE 57 46 16 34 30
DILTIAZEM 24HR ER 56 <11 <11 36 161
GLIPIZIDE 55 55 18 37 25
LORAZEPAM 53 29 17 B 38 29
TRIAMCINOLONE ACETONIDE 51 37 33 39 54
FENOFIBRATE* 50 36 11 40 74
OXYBUTYNIN CHLORIDE 50 45* 13 40 130
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.